Skip to main content
Log in

Mechanical Circulatory Support: a Look Back and a Look Ahead

  • Heart Failure (AM Chang, Section Editor)
  • Published:
Current Emergency and Hospital Medicine Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Heart failure is a growing problem across the world. Although many advances have been made in heart failure therapy, patients with cardiogenic shock still have a grim prognosis. The aim of this article is to discuss the current state of mechanical circulatory support and future directions.

Recent findings

Mechanical support can be classified as temporary or durable. Temporary support ranges from the intra-aortic balloon pump to extracorporeal membrane oxygenation. Durable support consists of left ventricular assist devices that are long-term and can be used as a bridge to transplant or destination therapy. Many advances continue be made in terms of size, thrombogenic potential, and infection risk.

Summary

As the supply of heart transplants is limited, mechanical support options for a growing heart failure population are becoming increasingly important. Deciding when to initiate and selecting the right device are of utmost importance and should be a multidisciplinary approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-Wilson PA, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83:505–10.

    Article  CAS  Google Scholar 

  2. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358–66.

    Article  Google Scholar 

  3. Singh M, White J, Hasdai D, Hodgson PK, Berger PB, Topol EJ, et al. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-1 trial. J Am Coll Cardiol. 2007;50:1752–8.

    Article  Google Scholar 

  4. Hochman JS, Sleeper LA, Web JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–34.

    Article  CAS  Google Scholar 

  5. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933–9.

    Article  CAS  Google Scholar 

  6. Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock design and rationale of the intraaortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial. Am Heart J. 2012;163(6):938–45.

    Article  Google Scholar 

  7. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240–327.

    PubMed  Google Scholar 

  8. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129.

    Article  Google Scholar 

  9. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–8.

    Article  Google Scholar 

  10. O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012;126:1717–27.

    Article  Google Scholar 

  11. Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015;34(12):1549–60.

    Article  Google Scholar 

  12. • Kuchibhotla S, Esposito ML, Breton C, et al. Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc. 2017;6(10) Established the efficacy of percutaneous biventricular support in the acute cardiogenic shock setting.

  13. Kapur N, Breton C, O'Kelly R, et al. Simultaneous, not staged, deployment of biventricular micro-axial flow Impella catheters (BiPella) is associated with improved survival for cardiogenic shock involving biventricular failure. J Am Coll Cardiol. 2016;68(18).

  14. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26.

    Article  Google Scholar 

  15. Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intra-aortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469.

    Article  Google Scholar 

  16. Ouweneel DM, Schotborgh JV, Limpens J. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med. 2016;42(12):1922–34.

    Article  Google Scholar 

  17. • Stub D, Bernard S, Pellegrino V, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015;86:88–94 Established the efficacy of ECMO during cardiac arrest and suggests it should be more widely used in this setting.

    Article  Google Scholar 

  18. •• Mehra M, Goldstein D, Uriel N, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378:1386–95 Demonstrated that the HeartMate 3 has better outcomes and lower rates of pump thrombosis compared with the previous HeartMate 2.

    Article  Google Scholar 

  19. McGee E, Chorpenning K, Brown M, et al. In vivo evaluation of the HeartWare MVAD Pump. J Heart Lung Transplant. 2014;33(4):366–71.

    Article  Google Scholar 

  20. Chiu W, Girdhar G, Xenos M, et al. Thromboresistance comparison of the HeartMate II ventricular assist device with the device thrombogenicity emulation-optimized HeartAssist 5 VAD. J Biomech Eng. 2014;136(2).

  21. Copeland J, Smith R, Arabia F, Nolan PE, Sethi GK, Tsau PH, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859–67.

    Article  CAS  Google Scholar 

  22. Carpentier A, Latremouille C, Cholley B, et al. First clinical use of a bioprosthetic total artificial heart: a report of two cases. Lancet. 2015;386.

    Article  Google Scholar 

  23. Pelletier B, Spiliopoulos S, Finocchiaro T, et al. System overview of the fully implantable destination therapy-ReinHeart-total artificial heart. Eur J Cardiothorac Surg. 2015;47(1):80–6.

    Article  Google Scholar 

  24. Goldsetin DJ, Naftel D, Holman W, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31(11):1151–17.

    Article  Google Scholar 

  25. Kapur N, Alkhouli M, DeMartini T, Faraz H, George ZH, Goodwin MJ, et al. Unloading the left ventricle before reperfusion in patients with anterior ST-segment–elevation myocardial infarction. Circulation. 2019;139:337–46.

    Article  Google Scholar 

  26. den Uil CA, Akin S, Jewbali L, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017;52:14–25.

    Article  Google Scholar 

  27. Shah P, Pagani F, Desai S, et al. Outcomes of patients receiving temporary circulatory support before durable ventricular assist device. Ann Thorac Surg. 2017;103:106–13.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan K. John.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Heart Failure

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

John, A.K., Pirlamarla, P. Mechanical Circulatory Support: a Look Back and a Look Ahead. Curr Emerg Hosp Med Rep 7, 189–195 (2019). https://doi.org/10.1007/s40138-019-00203-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40138-019-00203-3

Keywords

Navigation